Showing results (21-30 of 359) with videos related to
Sort By:
Pageof 36
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Serial 18F-FDG PET for Monitoring Treatment Response After Allogeneic Stem Cell Transplantation for MyelofibrosisThorsten Derlin, Haefaa Alchalby, Peter Bannas, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2022
Exploring Vessel Wall Biology In Vivo by Ultrasensitive Total-Body PETThorsten Derlin, Benjamin A Spencer, Martin Mamach, et al.Journal of Clinical Medicine|July 24, 2019
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CTRudolf A Werner, James T Thackeray, Martin G Pomper, et al.The Prostate|May 6, 2023
PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapyThorsten Derlin, Sabine Riethdorf, Udo Schumacher, et al.The Prostate|March 19, 2020
Influence of short-term dexamethasone on the efficacy of <sup>177</sup> Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerThorsten Derlin, Jan M Sommerlath Sohns, Sebastian Schmuck, et al.Theranostics|August 2, 2021
Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarctionRudolf A Werner, Annika Hess, Tobias Koenig, et al.Atherosclerosis|March 11, 2017
Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on <sup>18</sup>F-fluorodeoxyglucose positron emission tomographyDiana Ernst, Desiree Weiberg, Niklas T Baerlecken, et al.Cancers|April 3, 2021
Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine TumorsThorsten Derlin, Natalia Bogdanova, Fiona Ohlendorf, et al.Anticancer Research|March 19, 2017
<sup>68</sup>Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic TherapyChristoph Henkenberens, Christoph A VON Klot, Tobias L Ross, et al.European Radiology|March 25, 2016
<sup>68</sup>Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imagingThorsten Derlin, Desiree Weiberg, Christoph von Klot, et al.Pageof 36